Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Non-Current Assets: 2011-2019

Historic Non-Current Assets for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $33.5 million.

  • EyePoint Pharmaceuticals' Non-Current Assets rose 3.08% to $33.5 million in Q1 2019 from the same period last year, while for Mar 2019 it was $33.5 million, marking a year-over-year increase of 3.08%. This contributed to the annual value of $31.8 million for FY2018, which is 3289.65% up from last year.
  • As of Q1 2019, EyePoint Pharmaceuticals' Non-Current Assets stood at $33.5 million, which was up 9.54% from $30.6 million recorded in Q4 2018.
  • EyePoint Pharmaceuticals' 5-year Non-Current Assets high stood at $33.5 million for Q1 2019, and its period low was $552,000 during Q4 2017.
  • Its 3-year average for Non-Current Assets is $18.1 million, with a median of $30.6 million in 2018.
  • In the last 5 years, EyePoint Pharmaceuticals' Non-Current Assets slumped by 54.42% in 2017 and then spiked by 5,437.50% in 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Non-Current Assets (Quarterly) stood at $2.1 million in 2015, then plummeted by 42.00% to $1.2 million in 2016, then plummeted by 54.42% to $552,000 in 2017, then spiked by 5,437.50% to $30.6 million in 2018, then increased by 3.08% to $33.5 million in 2019.
  • Its Non-Current Assets was $33.5 million in Q1 2019, compared to $30.6 million in Q4 2018 and $31.2 million in Q3 2018.